NR3C1 and posterior cortical atrophy: Future follow-up studies should include racially/ethnically diverse mouse xenografts models (derived from both DTX-resistant PCa cell lines and DTX-resistant patient tumors [PDX]) treated with combinations of novel selective GR modulators (i.e., exicorilant and relacorilant), β-catenin inhibitors (MSAB) and DTX, to validate our in vitro results implicating the GR/β-catenin axis in PCa taxane resistance in diverse pre-clinical in vivo models.